174 related articles for article (PubMed ID: 17555452)
1. Intensity of HLA class I expression and KIR-mismatch determine NK-cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia.
Pfeiffer M; Schumm M; Feuchtinger T; Dietz K; Handgretinger R; Lang P
Br J Haematol; 2007 Jul; 138(1):97-100. PubMed ID: 17555452
[TBL] [Abstract][Full Text] [Related]
2. Cytolytic activity of NK cell clones against acute childhood precursor-B-cell leukaemia is influenced by HLA class I expression on blasts and the differential KIR phenotype of NK clones.
Feuchtinger T; Pfeiffer M; Pfaffle A; Teltschik HM; Wernet D; Schumm M; Lotfi R; Handgretinger R; Lang P
Bone Marrow Transplant; 2009 Jun; 43(11):875-81. PubMed ID: 19151793
[TBL] [Abstract][Full Text] [Related]
3. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia.
Romanski A; Bug G; Becker S; Kampfmann M; Seifried E; Hoelzer D; Ottmann OG; Tonn T
Exp Hematol; 2005 Mar; 33(3):344-52. PubMed ID: 15730858
[TBL] [Abstract][Full Text] [Related]
5. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
[TBL] [Abstract][Full Text] [Related]
7. Killer immunoglobulin-like receptors.
Moretta L; Moretta A
Curr Opin Immunol; 2004 Oct; 16(5):626-33. PubMed ID: 15342010
[TBL] [Abstract][Full Text] [Related]
8. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
[TBL] [Abstract][Full Text] [Related]
9. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
[TBL] [Abstract][Full Text] [Related]
10. The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.
Ruggeri L; Capanni M; Mancusi A; Martelli MF; Velardi A
Transpl Immunol; 2005 Aug; 14(3-4):203-6. PubMed ID: 15982564
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.
Ruggeri L; Mancusi A; Burchielli E; Perruccio K; Aversa F; Martelli MF; Velardi A
Semin Cancer Biol; 2006 Oct; 16(5):404-11. PubMed ID: 16916611
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell crossmatch: functional analysis of inhibitory killer immunoglobulin-like receptors and their HLA ligands.
Han M; Fallena M; Guo Y; Stastny P
Hum Immunol; 2007 Jun; 68(6):507-13. PubMed ID: 17509450
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia.
Velardi A; Ruggeri L; Mancusi A; Aversa F; Christiansen FT
Curr Opin Immunol; 2009 Oct; 21(5):525-30. PubMed ID: 19717293
[TBL] [Abstract][Full Text] [Related]
14. Self-tolerance of human natural killer cells lacking self-HLA-specific inhibitory receptors.
Hasenkamp J; Borgerding A; Uhrberg M; Falk C; Chapuy B; Wulf G; Jung W; Trümper L; Glass B
Scand J Immunol; 2008 Mar; 67(3):218-29. PubMed ID: 18226015
[TBL] [Abstract][Full Text] [Related]
15. Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference.
Locatelli F; Pende D; Maccario R; Mingari MC; Moretta A; Moretta L
Clin Immunol; 2009 Nov; 133(2):171-8. PubMed ID: 19481979
[TBL] [Abstract][Full Text] [Related]
16. Killer cell Ig-like receptors ligand-mismatched, alloreactive natural killer cells lyse primary solid tumors.
Re F; Staudacher C; Zamai L; Vecchio V; Bregni M
Cancer; 2006 Aug; 107(3):640-8. PubMed ID: 16804934
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation.
Dupont B; Hsu KC
Curr Opin Immunol; 2004 Oct; 16(5):634-43. PubMed ID: 15342011
[TBL] [Abstract][Full Text] [Related]
18. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
Hsu KC; Pinto-Agnello C; Gooley T; Malkki M; Dupont B; Petersdorf EW
Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
Kogure T; Mantani N; Sakai S; Shimada Y; Tamura J; Terasawa K
Mediators Inflamm; 2003 Apr; 12(2):117-21. PubMed ID: 12775362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
